Conflict-of-interest policy at the National Institutes of Health: The pendulum swings wildly

Kennedy Institute of Ethics Journal

Volumn 15, Issue 2, 2005, Pages 199-210

  Derenzo, Evan G ^a,b  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 23744476960     PISSN: 10546863     EISSN: None     Source Type: Journal    
DOI: 10.1353/ken.2005.0012     Document Type: Review

References (21)

1. Callahan, Daniel. 2003. What Price Better Health? Hazards of the Research Imperative. University of California Press: Berkeley and Los Angeles.
2. Downie, Jocelyn; Baird, Patricia; and Thompson, Jon. 2002. Industry and the Academy: Conflicts of Interest in Contemporary Health Research. Health Law Journal 10:103-22.
3. Eggen, Dan, and Weiss, Rick. 2005. Doctor Re-Reconsiders, Will Take NIH Job. Washington Post (18 May): A04.
4. Federal Register. 2005. Supplemental Standards of Ethical Conduct and Financial Disclosure Requirements for Employees of the Department of Health and Human Services: Interim Final Rule with Request for Comments. Thursday, 3 February. 70 (22): 5543-65. Available at http://www.nih.gov/about/ethics_COI. htm. Accessed 11 April 2005.
5. Finucane, Thomas E., and Boult, C. E. 2004. Association of Funding and Findings of Pharmaceutical Research at a Meeting of a Medical Professional Society. American Journal of Medicine 117: 876-78.
6. Helft, Paul R.; Ratain, Mark J.; Epstein Richard A.; and Siegler, Mark. 2004. Inside Information: Financial Conflicts of Interest for Research Subjects in Early Phase Clinical Trials. Journal of the National Cancer Institute 96: 656-61.
7. Kaufman, Marc. 2005. FDA Plans New Board to Monitor Drug Safety. Washington Post (15 February): A1.
8. Levinsky, Norman G. 2002. Nonfinancial Conflicts of Interest in Research. NEJM 347: 759-61.
9. Lux, Christina. 2002. Conflicts of Interest in Germany: A Legal Perspective. Science Engineering Ethics 8: 327-36.
10. Miller, Franklin G.; Rosenstein, Donald L.; and DeRenzo, Evan G. 1998. Professional Integrity in Clinical Research. JAMA 280: 1449-54.
11. Nersesyan, Armen K. 2002. Conflicts of Interest in Science in Armenia. Science Engineering Ethics 8: 291-93.
12. Press, Eyal, and Washburn, Jennifer. 2000. The Kept University. Atlantic Monthly 285 (3, March): 39-42, 45-48, 50-52, 54.
13. Rosenwald, Michael S. 2005. Biotech Industry Sees Potential in Ethics Rules. Washington Post (3 February): E01.
14. _, and Weiss, Rick. 2005. New Ethics Rules Cost NIH Another Top Researcher. Washington Post (2 April): A01.
15. Steinbrook, Robert. 2004. Financial Conflicts of Interest and the NIH. New England Journal of Medicine 350: 327-30.
16. Subcommittee on Oversight and Investigations. 2004. Hearings: "NIH Ethics Concerns: Consulting Arrangements and Outside Awards" before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, 22 June. Available at http://frwebgate. access.gpo.gov/cgi-bin/getdoc.cgi?dbname=108_house_hearings&docid=f:93973. wais. Accessed 9 May 2005.
17. Weiss, Rick. 2005a. NIH Will Restrict Outside Income. Washington Post (2 February): A01.
18. _. 2005b. NIH Clears Most Researchers in Conflict-of-interest Probe. Washington Post (23 February): A01.
19. Williams, Kevin M. 2004. Managing Physician Financial Conflicts of Interest in Clinical Trials Conducted in the Private Practice Setting. Food and Drug Law Journal 59(1): 45-77.
20. Willman, David. 2003. Stealth Merger: Drug Companies and Government Medical Research. Los Angels Times (7 December): A1, A32-A33.
21. Working Group of the Advisory Committee to the Director, National Institutes of Health. 2004. Report of the National Institutes of Health Blue Ribbon Panel on Conflict of Interest Policies. 22 June. Available at http://www.nih.gov/about/ethics_COI_panelreport.pdf. Accessed 11 April 2005.